Pretreatment With Estradiol Valerate

Summary

The present study is set up to evaluate the efficacy of a programmation by administration of estrogen valerate during 6 or more consecutive days. In this prospective randomised trial, we study the impact of administration of Progynova® during 6, 7,8 9 or 10 consecutive days during the luteo-follicular transition period of the menstrual cycle.

Timeline

Start

2010-05

Primary completion

2012-01

Completion

2012-01

Drugs

Indications